Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



In Stock

Add to Wishlist
Add to Wishlist


Zepzelca is a medicine with the active substance lurbinectedin, indicated for the treatment of adult patients suffering from relapsed or refractory diffuse large B-cell lymphoma (DLBCL). This type of non-Hodgkin lymphoma is characterized by the rapid development of abnormal B cells. The drug works by targeting the BCL-2 protein, which plays a key role in preventing cancer cell death. By targeting BCL-2, the drug helps destroy cancer cells.

Active ingredient: lurbinectedin

Prescription medicine